Linex forte tvrde kapsule
| Name | Linex forte tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-530766703 |
| Active Substance | LACTOBACILLUS ACIDOPHILUS BIFIDOBACTERIUM |
| Composition | jedna tvrda kapsula sadrži najmanje 1x109 CFU živih liofiliziranih mliječnih bakterija, acidofilnih LA-5 Lactobacillus acidophilus (LA-5) i 1 x 109 CFU živih liofiliziranih bifidobakterija, mliječnih BB-12 Bifidobacterium animalis subsp. lactis (BB-12) |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 15.10.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/610 |
| Registration Number | 381-12-01/30-19-09 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) and non-pharmacy outlets |
| Advertising to general public | allowed |
| ATC Code | A07FA01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
